Sabra director granted 8,310 stock units

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Rhea-AI Filing Summary

Kono Ann reported acquisition or exercise transactions in this Form 4 filing.

Sabra Health Care REIT, Inc. director Ann Kono received an equity award of 8,310 restricted stock units of common stock as compensation. The grant was made at no cash cost to her and is structured to vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the next annual stockholders' meeting.

Each unit represents the right to receive one share of Sabra’s common stock. Following this grant, Kono has an aggregate 68,186 stock units, including the 8,310 unvested units from this award and 55,016 units that have already vested but for which share delivery has been deferred.

Insights

Corporate governance analyst

Director received a routine stock unit grant as board compensation, with no open‑market buying or selling.

Director Ann Kono was granted 8,310 restricted stock units of Sabra Health Care REIT, Inc. common stock at a price of $0.00 per unit. This is a compensation-related equity award, not a market purchase, and therefore carries a weaker information signal than open‑market buying.

The units vest monthly from July 17, 2026 through the earlier of June 17, 2027 or the day before the next annual meeting, aligning board compensation with ongoing service. After this grant, Kono holds 68,186 stock units, combining unvested and vested-but-deferred units, indicating continuing equity exposure to Sabra shares.

Insider Trade Summary

Grant/Award: 8,310 shares

Grant/Award 1 txn

Insider Kono Ann

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock	8,310	$0.00	$0.00

Holdings After Transaction: Common Stock — 68,186 shares (Direct)

Footnotes (2)

1. F1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.
2. F2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Key Figures

Restricted stock units granted: 8,310 units Grant price: $0.00 per unit Total stock units after grant: 68,186 units +2 more

5 metrics

Restricted stock units granted 8,310 units Equity award to director Ann Kono on June 17, 2026

Grant price $0.00 per unit Compensation-related stock unit grant

Total stock units after grant 68,186 units Director Ann Kono’s aggregate stock units following transaction

Vested but deferred units 55,016 units Vested stock units with deferred payment

Unvested units from this grant 8,310 units Newly granted restricted stock units

Key Terms

restricted stock units, 2009 Performance Incentive Plan, vest, deferred

4 terms

restricted stock units financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

2009 Performance Incentive Plan financial

"Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan."

vest financial

"The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

deferred financial

"Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred."

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What did Sabra Health Care REIT (SBRA) director Ann Kono receive in this Form 4?

Director Ann Kono received an award of 8,310 restricted stock units of Sabra Health Care REIT common stock. The grant was made at $0.00 per unit as equity compensation rather than a market purchase.

How and when do Ann Kono’s new Sabra Health Care (SBRA) stock units vest?

The 8,310 restricted stock units vest in equal monthly installments starting July 17, 2026. Vesting continues until the earlier of June 17, 2027 or the day before Sabra’s next annual stockholders’ meeting.

How many Sabra Health Care (SBRA) stock units does Ann Kono hold after this transaction?

After this award, Ann Kono holds a total of 68,186 stock units. This includes 8,310 unvested units from the new grant and 55,016 units that have vested but whose share delivery has been deferred.

Does this Sabra Health Care (SBRA) Form 4 show an open-market stock purchase or sale?

No. The Form 4 reports a grant of restricted stock units, coded as a compensation-related acquisition. The transaction price is listed as $0.00 per share, indicating no open-market buying or selling occurred here.

What does each Sabra Health Care (SBRA) stock unit in this grant represent?

Each unit represents the right to receive one share of Sabra common stock. Some units are unvested and will vest over time, while other units have vested but their share delivery has been deferred according to the plan’s terms.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 06/18/2026 - 06:34 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Kono Ann

(Last) (First) (Middle)

C/O SABRA HEALTH CARE REIT, INC.

1781 FLIGHT WAY

(Street)

TUSTIN CALIFORNIA 92782

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Sabra Health Care REIT, Inc. [ SBRA ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/17/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	06/17/2026		A		8,310(1)	A	$0	68,186(2)	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Grant of restricted stock units under the Issuer's 2009 Performance Incentive Plan. The units vest in equal monthly installments beginning July 17, 2026 and ending on the earlier of June 17, 2027 or the day before the date of the next annual stockholders' meeting.

2. Includes 8,310 unvested stock units and 55,016 stock units that have vested but the payment of which has been deferred. Each stock unit represents the right to receive one share of the Issuer's Common Stock.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney

	/s/ Michael Costa, as Attorney-in-Fact	06/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)